Gene targeting in vivo by adeno-associated virus vectors

[1]  D. Russell,et al.  Gene targeting with viral vectors. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  D. Russell,et al.  Gene targeting by adeno-associated virus vectors is cell-cycle dependent. , 2005, Human gene therapy.

[3]  W. Colledge,et al.  A LacZ-based transgenic mouse for detection of somatic gene repair events in vivo , 2004, Gene Therapy.

[4]  James M. Allen,et al.  Systemic delivery of genes to striated muscles using adeno-associated viral vectors , 2004, Nature Medicine.

[5]  J. Engelhardt,et al.  Targeted Correction of Single-Base-Pair Mutations with Adeno-Associated Virus Vectors under Nonselective Conditions , 2004, Journal of Virology.

[6]  Angelique M. Nelson,et al.  Utility of a C57BL/6 ES line versus 129 ES lines for Targeted Mutations in Mice , 2003, Transgenic Research.

[7]  Theresa A. Storm,et al.  Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy. , 2003, Blood.

[8]  Daniel G. Miller,et al.  Human Gene Targeting by Adeno-Associated Virus Vectors Is Enhanced by DNA Double-Strand Breaks , 2003, Molecular and Cellular Biology.

[9]  D. Russell,et al.  Targeted transgene insertion into human chromosomes by adeno-associated virus vectors , 2002, Nature Biotechnology.

[10]  A. Orpana,et al.  Accuracy in amplification , 2001, Nature Biotechnology.

[11]  R. Schreiber,et al.  Mucopolysaccharidosis type VII (Sly syndrome) presenting as neonatal cholestasis with hepatosplenomegaly. , 2001, Journal of pediatric gastroenterology and nutrition.

[12]  J. S. Owen,et al.  Gene repair validation , 2001, Nature Biotechnology.

[13]  H. Scheffer,et al.  Persistent failures in gene repair , 2001, Nature Biotechnology.

[14]  M. Abramowicz,et al.  Chimeraplasty validation , 2001, Nature Biotechnology.

[15]  P. Glazer,et al.  Specific mutations induced by triplex-forming oligonucleotides in mice. , 2000, Science.

[16]  D. Russell,et al.  High-Fidelity Correction of Mutations at Multiple Chromosomal Positions by Adeno-Associated Virus Vectors , 1999, Journal of Virology.

[17]  C. Steer,et al.  Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotide. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Sands,et al.  Percutaneous intravenous injection in neonatal mice. , 1999, Laboratory animal science.

[19]  B. Byrne,et al.  Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield , 1999, Gene Therapy.

[20]  Philippe Soriano.  Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[21]  D. Grimm,et al.  Novel tools for production and purification of recombinant adenoassociated virus vectors. , 1998, Human gene therapy.

[22]  D. Russell,et al.  Human gene targeting by viral vectors , 1998, Nature Genetics.

[23]  J. Vijg,et al.  Erratum: Transgenic mouse models for studying mutations in vivo: Applications in aging research (Mechanisms of Ageing and Development (1997) 98 (189-202)) , 1997 .

[24]  J. Vijg,et al.  Transgenic mouse models for studying mutations in vivo: applications in aging research , 1997, Mechanisms of Ageing and Development.

[25]  D. Russell,et al.  Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  W. Sly,et al.  High level expression and export of beta-glucuronidase from murine mucopolysaccharidosis VII cells corrected by a double-copy retrovirus vector. , 1995, Gene therapy.

[27]  M. Sands,et al.  A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W. Sly,et al.  Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[29]  J Vijg,et al.  Plasmid rescue from transgenic mouse DNA using LacI repressor protein conjugated to magnetic beads. , 1993, BioTechniques.

[30]  M. Sands,et al.  Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer , 1992, Nature.

[31]  M. Davisson,et al.  Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency. , 1989, The Journal of clinical investigation.

[32]  J. Vijg,et al.  E. coli C: a convenient host strain for rescue of highly methylated DNA. , 1988, Nucleic acids research.